Cancer Proteome & Biomarkers
Proteomics technologies are used for early detection and diagnosis of cancers for the development of novel therapeutic agents. Identification of biomarker and also the study of protein expression of the cancer are studied through proteomics platforms. These studies have led to the development of discovering new drugs and targeted therapeutics towards the tumour cells. Detection, prognosis, diagnosis and therapy of breast cancer is now possible with the advancements in the field of proteomics along with the use of mass spectrometry. The discovery of the protein patterns has enabled researchers to distinguish the disease and disease free-state associated with breast cancer has been uncovered with the development of proteomics technologies. This discovery leads to personalized therapy for the patients. Proteins expressed or found in the serum, plasma and the tumour cells using the novel methodologies provide a better view of the heterogeneity of the cancers.